Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X about a paper by Maise Al Bakir et al. published in Nature:
“EGFRm Lung cancer.
A study of recurrent cases treated with osimertinib plus tumor-specific neoantigen. Most of them transformed to small cell lineages, and neoantigen expression was decreased in liver metastasis cases.
The paper found that genome doubling was behind this acquisition of resistance and that phylogenetic analysis would be useful.”
“Clonal driver neoantigen loss under EGFR TKI and immune selection pressures”
Authors: Maise Al Bakir, James Reading, Samuel Gamble, Rachel Rosenthal, Imran Uddin, Sine Reker Hadrup, Benny Chain, Sergio Quezada, Nicholas McGranahan, Charles Swanton et al.
More posts featuring Katsuaki Maehara.